Abbott is the name behind many well-known products.

Abbott Laboratories has a great financial position. The long-term debt/equity ratio is 0.3, while the interest coverage ratio is 17. See why ABT stock is a buy.

Quick Read Abbott Laboratories (ABT) raised its quarterly dividend to $0.63 with a 60.4% free cash flow payout ratio.

Abbott Laboratories has been essentially flat over the last 15 months, underperforming the S&P 500's 17.5% total return. Q3 2025 results showed normalized EPS in line at $1.30, with revenue up nearly ...

Income-oriented investors will appreciate Abbott's excellent dividend program. 10 stocks we like better than Abbott ...

Dividend-paying stocks that combine healthy balance sheets with hefty yields can provide investors with steady incomes, cushion against market downturns, and increase investments at a healthy clip. To ...

Abbott Labs stock hit a 52-week low after an earnings miss, but CEO Robert Ford isn't flinching. Here is why his $2 million ...

Abbott Laboratories (NYSE: ABT) will release its fiscal fourth-quarter earnings report next Thursday before the opening bell, setting up an intriguing idea for bullish options traders. Ordinarily, ABT ...

This Dividend King has staying power.